The stock of Allergan plc Ordinary Shares (NYSE:AGN) is a huge mover today! The stock increased 3.63% or $9.72 during the last trading session, hitting $277.81. About 6.36 million shares traded hands or 92.15% up from the average. Allergan plc Ordinary Shares (NYSE:AGN) has declined 11.04% since August 27, 2015 and is downtrending. It has underperformed by 17.86% the S&P500. The move comes after 8 months positive chart setup for the $105.93 billion company. It was reported on Apr, 5 by Barchart.com. We have $355.60 PT which if reached, will make NYSE:AGN worth $29.66B more.
Out of 15 analysts covering Allergan Inc. (NYSE:AGN), 17 rate it “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Allergan Inc. was the topic in 27 analyst reports since July 29, 2015 according to StockzIntelligence Inc. Mizuho maintained the stock on February 23 with “Buy” rating.
According to Zacks Investment Research, “Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.”
The institutional sentiment decreased to 0.55 in 2015 Q3. Its down 5.45, from 6 in 2015Q2. The ratio fall, as 14 funds sold all Allergan plc Ordinary Shares shares owned while 6 reduced positions. 6 funds bought stakes while 5 increased positions. They now own 68,008 shares or 81.40% less from 365,652 shares in 2015Q2.
Peregrine Asset Advisers Inc. holds 3.11% of its portfolio in Allergan plc Ordinary Shares for 11,219 shares. Chartist Inc Ca owns 2,012 shares or 1.95% of their US portfolio. Moreover, Altavista Wealth Management Inc. has 1.78% invested in the company for 9,960 shares. The Virginia-based Old Dominion Capital Management Inc has invested 1.51% in the stock. Mitchell Mcleod Pugh & Williams Inc, a Alabama-based fund reported 4,175 shares.
Allergan plc Ordinary Shares - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.
